Header Logo

Connection

Raid Aljumaily to Combined Modality Therapy

Back to Details
This is a "connection" page, showing publications Raid Aljumaily has written about Combined Modality Therapy.
Raid Aljumaily
Connection Strength
0.026
Combined Modality Therapy
  1. Phase II study of low-dose paclitaxel with timed thoracic radiotherapy followed by adjuvant gemcitabine and carboplatin in unresectable stage III non-small cell lung cancer. Lung Cancer. 2014 Jan; 83(1):67-72.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.